Machine learning for protein engineering at PEGS Europe 2026

Nov 16–19, 2026 Lisbon, Portugal ~1.5k attendees Website

58 organizations at PEGS Europe 2026 present work in machine learning for protein engineering: 33 suppliers and service providers, 20 academic, government and non-profit bodies and 5 drug developers. Between them they bring 109 presentations to the program. Most represented: AstraZeneca (12 on the program), iBET (7 on the program), Sanofi (4 on the program). As of Oct 8, 2026.

All 541 organizations at PEGS Europe 2026 →

Showing 1–7 of 58 organizations

Organization	PEGS Europe 2026 Attendance
AstraZeneca Cambridge, UK
astrazeneca.com Large pharma Global pharmaceutical company with oncology, immunology, respiratory and rare disease medicines, including antibodies and ADCs.	Talk Tue Nov 17 9:30am–10:00am Building the Protein Lab of the Future at AstraZeneca: Automation First Science and AI Ready Data at Scale Leveraging Data Science for Enhanced Protein Expression Chair Tue Nov 17 11:44am–11:45am Chairperson's Remarks Display of Biologics Chair Tue Nov 17 2:00pm–2:05pm Chairperson's Remarks Display of Biologics Talk Tue Nov 17 5:20pm–5:50pm Machine Learning for Lead Optimisation Workflow (MeLLOw): Integrating in silico and Wet Lab Data for Biologics Engineering Optimisation & Developability Panel Tue Nov 17 5:50pm–6:20pm BEST PRACTICES FOR IN SILICO DESIGN OF ANTIBODIES: What We Know Now Display of Biologics · with Specifica, Merck KGaA, Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI) Talk Tue Nov 17 5:50pm–6:20pm Engineering Affinity Attenuated and Effector CD8 Biased T Cell Engagers T Cell Engagers Chair Wed Nov 18 8:25am–8:30am Chairperson’s Remarks Machine Learning for Protein Engineering Part 1 Talk Wed Nov 18 11:15am–11:45am Stability Prediction for Multispecific Antibodies Machine Learning for Protein Engineering Part 1 Talk Wed Nov 18 11:45am–12:15pm Application of Expression Strategies for Integral Membrane Protein Production Designing High-Performance Expression Platforms Chair Thu Nov 19 8:25am–8:30am Chairperson's Remarks Highly Parallel Protein Discovery Workflows Talk Thu Nov 19 8:30am–8:50am Evolutionary Algorithms for Peptide Design and Optimisation Novel Peptide Drug Discovery Talk Thu Nov 19 9:00am–9:30am Next-Generation Protein Characterisation: An Integrated Mass Spectrometry Strategy from Structured Proteins to Intrinsically Disordered Proteins Highly Parallel Protein Discovery Workflows Talk Thu Nov 19 11:15am–11:45am Targeting Peptides for Enhanced Tissue Delivery Novel Peptide Drug Discovery Talk Thu Nov 19 11:45am–12:05pm AI for Biologics: Transition from Discovery to Design Machine Learning for Protein Engineering Part 2 Talk Thu Nov 19 5:15pm–5:45pm Optimal Design of Masks for Protease-Activated Biologics: What Works, What Doesn’t, and Why Next-Generation Immunotherapies
iBET Oeiras, Portugal	◆Corporate Support Sponsor
ibet.pt AcademicCorporate Support Sponsor Portuguese non-profit research institute doing protein production, antibody discovery and bioprocess work, including contract research for industry.	Booth Exhibiting at Booth 123 Tue, Nov 1710:30am–7:50pmWed, Nov 1810:30am–5:30pmThu, Nov 1910:00am–2:00pm Chair Tue Nov 17 8:25am–8:30am Chairperson's Welcome Remarks Leveraging Data Science for Enhanced Protein Expression Talk Tue Nov 17 5:20pm–5:50pm The Development of iSeRa-AI, a Tool for Automatic Selection of mAbs from Antibody Display Coupled to Deep Sequencing Display of Biologics Talk Tue Nov 17 5:50pm–6:20pm 3D Tumour Microenvironments Enable Mechanistic Profiling of ADCs and Immunomodulatory Antibodies Safety and Efficacy of Bispecific and Multispecific Antibodies Talk Wed Nov 18 11:15am–11:45am Integrating Genome-Wide CRISPR Screening and Host Cell Engineering in HeLaS3 Producer Lines for rAAV Production Designing High-Performance Expression Platforms Talk Wed Nov 18 7:00pm–7:30pm Decoding Macrophage-Fibroblast Cross-Talk to Enable Next-Generation Anti-Fibrotic Therapies Analytical Characterisation of Biotherapeutics Talk Thu Nov 19 8:30am–9:00am Advanced Bioanalytics for Comprehensive Characterisation of Biotherapeutics Manufacturing Highly Parallel Protein Discovery Workflows Panel Thu Nov 19 5:05pm–5:45pm Higher-Throughput Biopharmaceutical Workflow Challenges Highly Parallel Protein Discovery Workflows · with University of Surrey, University College London, Septerna +1 more
Sanofi Paris, France
sanofi.com Large pharma French pharmaceutical company developing antibodies, Nanobody molecules, multispecifics and other biologics across immunology, oncology and rare diseases.	Talk Wed Nov 18 9:30am–10:00am Structural Biology at the Forefront of Biotherapeutics: Cryo-EM, AI, and Complex Modalities Analytical Characterisation of Biotherapeutics Talk Thu Nov 19 9:00am–9:30am Colloidal Stability Prediction of Multivalent NANOBODY Molecules Using Machine Learning Protein Stability & Formulation Chair Thu Nov 19 10:44am–10:45am Chairperson's Remarks Machine Learning for Protein Engineering Part 2 Talk Thu Nov 19 11:05am–11:25am De novo VHH Design in Practice: Bridging AI Innovation with Real-World Biologics Design Machine Learning for Protein Engineering Part 2 Talk Thu Nov 19 5:15pm–5:45pm Precision-Activated T Cell Engagers in Immuno-Oncology: Pharmacological Characterisation of Albumin-Masked TCR Multispecific VHHs Engineering the Next Generation of Bispecific Antibodies
Novo Nordisk Bagsværd, Denmark
novonordisk.com Large pharma Danish pharmaceutical company known for diabetes and obesity medicines, with in-house protein and peptide drug discovery.	Talk Tue Nov 17 9:00am–9:30am IVTT-Accelerated Protein Discovery: Generating Fit-for-Purpose AI Training Data Leveraging Data Science for Enhanced Protein Expression Talk Wed Nov 18 6:30pm–7:00pm High-Throughput Automation Platform for Miniaturised Biophysical Assays: Accelerating Compound Screening with One Click Analytical Characterisation of Biotherapeutics Talk Thu Nov 19 8:50am–9:10am Long Acting, Stable Urocortin-2 Analogues for the Treatment of Obesity and Diabetes Novel Peptide Drug Discovery Talk Thu Nov 19 2:05pm–2:35pm Real-World Progress, Challenges, and Opportunities for AI in Protein and Peptide Discovery Novel Peptide Drug Discovery
Specifica Santa Fe, NM
specifica.bio Discovery platforms IQVIA antibody discovery business offering Generation 3 and VHH display libraries, discovery and optimisation services, and platform transfer.	Panel Tue Nov 17 5:50pm–6:20pm BEST PRACTICES FOR IN SILICO DESIGN OF ANTIBODIES: What We Know Now Display of Biologics · with AstraZeneca, Merck KGaA, Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI) Talk Wed Nov 18 12:15pm–12:45pm Evolution of Specifica’s Gen3 Technology: Functional Bispecifics Directly from Constant Light Chain Libraries Engineering Antibodies & Beyond Panel Thu Nov 19 3:36pm–4:14pm Appropriate Use of Agentic AI in the Lab Machine Learning for Protein Engineering Part 2 · with Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI) Chair Thu Nov 19 4:14pm–4:15pm Chairperson's Remarks Machine Learning for Protein Engineering Part 2
University of Surrey Guildford, UK
	Panel Tue Nov 17 6:20pm–6:50pm Beyond the Bench: Harnessing Data to Advance Protein Science Leveraging Data Science for Enhanced Protein Expression · with University College London, Data Powered Therapeutics, Adaptyv Bio +1 more Talk Thu Nov 19 10:45am–11:15am Immune Checkpoint Inhibitor Therapies: Building on the Revolution to Improve Patient Outcomes Next-Generation Immunotherapies Talk Thu Nov 19 2:05pm–2:35pm Considerations for Integrating Workflows for Protein Production and Characterisation to Enable Quality Data Generation for Building ML Models Highly Parallel Protein Discovery Workflows Panel Thu Nov 19 3:35pm–4:15pm Clinical Outcomes in Immunotherapy—Where Are We Now? Next-Generation Immunotherapies · with Accession Therapeutics, BioInvent, Immatics +2 more Panel Thu Nov 19 5:05pm–5:45pm Higher-Throughput Biopharmaceutical Workflow Challenges Highly Parallel Protein Discovery Workflows · with University College London, Septerna, iBET +1 more
Helmholtz Centre for Infection Research Braunschweig, Germany
	Panel Tue Nov 17 6:20pm–6:50pm Beyond the Bench: Harnessing Data to Advance Protein Science Leveraging Data Science for Enhanced Protein Expression · with University College London, University of Surrey, Data Powered Therapeutics +1 more Talk Wed Nov 18 6:00pm–6:30pm Reshaping Adoptive T Cell Therapies with T Memory Cell–Based Strategies, Control of Graft-Versus-Host Disease (GVHD), and Modulation of the Tumour Microenvironment (TME) Advances in Immunoengineering Talk Wed Nov 18 7:15pm–7:40pm A Molecular Playground: Building Virus-Like-Particles in Insect Cells Designing High-Performance Expression Platforms